These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7911406)

  • 1. [The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
    Paterna S; Martino S; Ingurgio NC; Arrostuto A; Correo S; Licata G
    Clin Ter; 1994 Apr; 144(4):307-19. PubMed ID: 7911406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An open randomized comparative trial of efficacy and safety of selective alpha-adrenoblocker setegis (terazosin) in therapy of patients with chronic bacterial prostatitis].
    Trapeznikova MF; Morozov AP; Dutov VV; Urenkov SB; Pozdniakov KV; Bychkova NV
    Urologiia; 2007; (2):33-7. PubMed ID: 17578197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group].
    Fourcade RO
    Prog Urol; 2000 Apr; 10(2):246-53. PubMed ID: 10857142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    ; Leizorovicz A; Becker F
    Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of the effect of buflomedil on peripheral neuropathy in diabetic patients].
    Zhou M; Lei MX
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):239-40. PubMed ID: 12536693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
    Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
    Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
    Lombardini R; Ciuffetti G; Paltriccia R; Scarponi AM; Savastano V; Palazzetti D; Mercuri M; Parnetti L
    Ric Clin Lab; 1989; 19 Suppl 1():117-9. PubMed ID: 2629069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical efficacy and safety of terazosine (setegis) in patients with benign prostatic hyperplasia with concomitant cardiovascular diseases].
    Trapeznikova MF; Gurevich MA; Pozdniakov KV; Tazina SIa; Bychkova NV
    Urologiia; 2005; (2):50-3. PubMed ID: 15989029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention].
    Yang C; Li YL; Fang J; Zhang X; Liu HP; Qin XH; Xu XP
    Zhonghua Nan Ke Xue; 2009 May; 15(5):441-4. PubMed ID: 19514558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)].
    Foray J; Baisse PE; Mont JP; Cahen C
    Sem Hop; 1980 Mar 8-15; 56(9-10):490-7. PubMed ID: 6244676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M; Albiani B; Ricci M; Russo F
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patterns of use of terazosine in current medical practice in ambulatory patients with obstructive and irritative obstructive disorders of urination].
    Serment G; Rossi D; Reitz C; Boumendil O
    Prog Urol; 2000 Apr; 10(2):254-60. PubMed ID: 10857143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
    Montemurro NE; Damiano M
    Clin Ter; 1986 Mar; 116(6):485-9. PubMed ID: 3720235
    [No Abstract]   [Full Text] [Related]  

  • 16. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis.
    Witjes WP; Rosier PF; Caris CT; Debruyne FM; de la Rosette JJ
    Urology; 1997 Feb; 49(2):197-205; discussion 205-6. PubMed ID: 9037281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terazosin in the treatment of premature ejaculation: a short-term follow-up.
    Başar MM; Yilmaz E; Ferhat M; Başar H; Batislam E
    Int Urol Nephrol; 2005; 37(4):773-7. PubMed ID: 16362597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index.
    Gül O; Eroğlu M; Ozok U
    Int Urol Nephrol; 2001; 32(3):433-6. PubMed ID: 11583367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.